Pfizer, BioNTech Say Combination COVID-Flu Vaccine Generated Strong Immune Response In Trial

Reuters (10/26, Mishra) reports, “Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early- to mid-stage trial.” In the study, “the vac...